BUY Piramal Pharma Limited — Somil Mehta, Sharekhan
bySomil Mehta, SharekhanHorizon: NA (inferred Swing (≤2wk))3 Jul 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·27 May · 1mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Piramal Pharma
- BUY — Nirav Chheda, Nirmal Bang Securities24 Sept 2026 · ~1 year · target ₹250 · Active
- BUY — Rakesh Bansal24 Sept 2026 · Same day · target ₹219 · SL hit
- BUY — Goldman Sachs24 Sept 2026 · ~1 year · target ₹250 · Active
- BUY — Sacchitanand Uttekar, Tradebulls Securities22 Sept 2026 · ~3 months · target ₹230 · SL hit
- BUY — Siddharth Rai Mangala21 Sept 2026 · ~2 weeks · target ₹230 · SL hit
More from Somil Mehta, Sharekhan
- BUY JK Cement21 Oct 2026 · ~3 months · target ₹5,500 · Active
- BUY PVR INOX21 Oct 2026 · ~3 months · target ₹1,520 · Active
- BUY L&T Technology Services21 Oct 2026 · ~1 year · target ₹5,500 · Active
- BUY State Bank of India21 Oct 2026 · ~3 months · target ₹1,050 · Active
- BUY Union Bank of India21 Oct 2026 · ~3 months · target ₹190 · Active

